Sattva Sukun Lifecare Ltd promoter Roshan Dealmark Private Limited disposed of 14,00,000 equity shares through an on-market transaction on September 7, 2026. The sale reduces the promoter group’s aggregate stake in the company to 5.66%.

The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Roshan Dealmark is part of the promoter group acting in concert with Puja Agarwal.

Holding Changes

Before the transaction, Roshan Dealmark held 2,30,49,777 shares, while Puja Agarwal held 80,000 shares. The combined promoter group stake stood at 2,31,29,777 shares, representing 6.02% of the total diluted share capital.

Following the disposal, Roshan Dealmark’s holding decreased to 2,16,49,777 shares. Puja Agarwal’s stake remained unchanged at 80,000 shares. The total promoter group holding now stands at 2,17,29,777 shares.

The company’s paid-up equity capital remains unchanged at ₹38,36,01,248, comprising 383,601,248 shares of ₹1 each. The transaction was executed entirely through on-market trades on the Bombay Stock Exchange.

Tavexia Lifecare Limited (formerly Sattva Sukun Lifecare Limited) announced that M/s. SSRV and Associates has resigned as its statutory auditor with immediate effect on September 7, 2026.

The chartered accountancy firm cited preoccupation with other professional assignments and workload constraints as the reason for stepping down. The resignation was communicated to the Board of Directors via a letter dated September 7, 2026.

Auditor Tenure and Transition

SSRV and Associates was originally appointed as the statutory auditor on September 30, 2023. The Board of Directors had approved their reappointment for a second term of five consecutive years in August 2023, covering the period until the conclusion of the 48th Annual General Meeting.

The firm submitted its latest limited review report for the quarter ended June 30, 2026, on August 4, 2026. This filing occurred approximately one month prior to the resignation notification.

Regulatory Disclosures

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Tavexia Lifecare filed the intimation with the Bombay Stock Exchange. The disclosure aligns with Part A of Schedule III of the regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026.

The auditor confirmed there were no reportable concerns requiring communication to the Audit Committee or the Board prior to resignation. Consequently, no such communication was made during the tenure.

SSRV and Associates issued a No Objection Certificate (NOC) allowing the company to appoint a new eligible auditor to fill the casual vacancy. The company is required to complete applicable statutory filings with the Registrar of Companies and stock exchanges.